Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension

Chest

Volumn 150, Issue 1, 2016, Pages 256-258

  Savale, Laurent ^a,b,c   Chaumais, Marie Camille ^a,c,d   Montani, David ^a,b,c   Jaïs, Xavier ^a,b,c   Hezode, Christophe ^g   Antonini, Teresa Maria ^a,e,f   Coilly, Audrey ^a,e,f   Duclos Vallée, Jean Charles ^a,e,f   Samuel, Didier ^a,e,f   Simonneau, Gerald ^a,b,c   Humbert, Marc ^a,b,c   Sitbon, Olivier ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e HÔPITAL PAUL BROUSSE   (France)

^f INSERM   (France)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BOSENTAN; DACLATASVIR; DIRECT ACTING ANTIVIRAL; RIBAVIRIN; SILDENAFIL; SIMEPREVIR; SOFOSBUVIR; SOFOSBUVIR PLUS DACLATASVIR; SOFOSBUVIR PLUS RIBAVIRIN; SOFOSBUVIR PLUS SIMEPREVIR; SOFOSBUVIR PLUS SIMEPREVIR PLUS DACLATASVIR PLUS RIBAVIRIN; TADALAFIL; UNCLASSIFIED DRUG;

FOLLOW UP; HEPATITIS C; HUMAN; LETTER; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; CHRONIC HEPATITIS C; HEPACIVIRUS;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PULMONARY;

EID: 84990070543     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.04.031     Document Type: Letter

References (4)

1. 1 Renard, S., Borentain, P., Salaun, E., et al. Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir. Chest 149:3 (2016), e69–e73.
2. 2 Galie, N., Humbert, M., Vachiery, J.L., et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 46:4 (2015), 903–975.
3. 3 Savale, L., Sattler, C., Gunther, S., et al. Pulmonary arterial hypertension in patients treated with interferon. Eur Respir J 44:6 (2014), 1627–1634.
4. 4 Savale, L., Chaumais, M.C., Sitbon, O., Humbert, M., Pulmonary arterial hypertension in patients treated with interferon. Eur Respir J 46:6 (2015), 1851–1853.